Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Feb 11, 2025
SEATTLE, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read more at globenewswire.com
